Biogen (BIIB) Income from Non-Controlling Interests (2009 - 2023)

Biogen has reported Income from Non-Controlling Interests for 13 years, with the latest figure at -$800000.0 in Q4 2023.

• On a quarterly basis, Income from Non-Controlling Interests rose 11.11% year-over-year to -$800000.0 in Q4 2023; TTM through Sep 2024 was -$800000.0, a 366.67% decrease from a year earlier, with the FY2023 full-year figure at $400000.0, up 100.47% from the prior year.
• Income from Non-Controlling Interests was -$800000.0 for Q4 2023 at Biogen, down from -$200000.0 in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $577.0 million in Q2 2021, with the low at -$388.7 million in Q4 2021.
• Average Income from Non-Controlling Interests over 4 years is $9.2 million, with a median of -$300000.0 recorded in 2020.
• The largest YoY upside for Income from Non-Controlling Interests was 795.96% in 2021 against a maximum downside of 129466.67% in 2021.
• Over 4 years, Income from Non-Controlling Interests stood at -$300000.0 in 2020, then sank by 129466.67% to -$388.7 million in 2021, then soared by 99.77% to -$900000.0 in 2022, then advanced by 11.11% to -$800000.0 in 2023.
• The last three Income from Non-Controlling Interests figures came in at -$800000.0 (Q4 2023), -$200000.0 (Q3 2023), and $1.7 million (Q2 2023), per Business Quant data.